WallabyPhenox Revenue
Medical Equipment Manufacturing • 
Bochum, North Rhine-Westphalia, Germany • 201-500 Employees
WallabyPhenox revenue & valuation
| Annual revenue | $15,000,000 |
| Revenue per employee | $70,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $48,000,000 |
| Total funding | No funding |
Key Contact at WallabyPhenox
Company overview
| Headquarters | Lise-Meitner-Allee 31, Bochum, NRW 44801, DE |
| Phone number | +4949234369190 |
| Websites | |
| NAICS | 3391 |
| SIC | 384 |
| Keywords | Medical Devices, Medical Technology, Interventional Neuroradiology, Medtech, Neuroradiology, Balloon Catheters, Aneurysm Treatment Devices, Flow Modulation Devices, Hydrophilic Polymer Coatings, Ischemic Stroke Treatment Devices, Microguidewires, Thrombectomy Devices, Bifurcation Aneurysm Implants |
| Founded | 2005 |
| Employees | 201-500 |
| Socials |
WallabyPhenox Email Formats
WallabyPhenox uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@phenox.info), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@phenox.info | 85.8% |
{first initial}.{last name} | j.doe@phenox.com | 12.6% |
About WallabyPhenox
Since its founding in 2005, phenox has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases. phenox's products are used by endovascular specialists to treat ischemic and hemorrhagic stroke. The company offers a growing portfolio of innovative treatment options, including the primary interventional technologies used today. The product portfolio comprises the Mechanical Thrombectomy System pRESET, the p64, p48 MW and p64 MW Flow Diverters for the treatment of complex intracranial aneurysms and dissections as well as the pCONUS Implant for the treatment of complex, wide-neck bifurcation aneurysms. The specially developed HPC Technology (Hydrophilic Polymer Coating) for aneurysm treatment products leads to a reduction in the thrombogenicity of the implant surface and thus to an increased patient safety. Since 2020 phenox has also been the exclusive distributor of the Avenir Coiling System developed in California (USA) by Wallaby Medical. In 2022, Wallaby Medical, a global innovative medical technology company focused on developing and commercializing neurovascular interventional products for treating stroke, announced that it has acquired phenox GmbH, including phenox’s femtos GmbH. This acquisition then lead to rebranding of previously phenox GmbH to WallabyPhenox. Visit our website for further information about phenox and our products: https://www.phenox.net/ Imprint: https://phenox.net/international/imprint/
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
WallabyPhenox has 93 employees across 14 departments.
Departments
Number of employees
Funding Data
WallabyPhenox has never raised funding before.
WallabyPhenox Tech Stack
Discover the technologies and tools that power WallabyPhenox's digital infrastructure, from frameworks to analytics platforms.
UI frameworks
Cookie compliance
Mobile frameworks
JavaScript libraries
Maps
UI frameworks
Recruitment & staffing
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Netherlands
United Kingdom
Spain
Frequently asked questions
4.8
40,000 users
